Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

ABSTRACT:

Background

The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees.

Objective

To evaluate the conditions under which stool DNA testing could be cost-effective compared with the colorectal cancer screening tests currently reimbursed by the Centers for Medicare & Medicaid Services.

Design

Comparative microsimulation modeling study using 2 independently developed models.

Data sources

Derived from literature.

Target population

A cohort of persons aged 65 years. A sensitivity analysis was also conducted, in which a cohort of persons aged 50 years was studied.

Time horizon

Lifetime.

Perspective

Third-party payer.

Intervention

Stool DNA test ever

SUBMITTER: Lansdorp-Vogelaar I 

PROVIDER: S-EPMC3578600 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature